Campagne de collecte 15 septembre 2024 – 1 octobre 2024 C'est quoi, la collecte de fonds?

FDA in the Twenty-First Century

Main
Business & Economics - Industries
FDA in the Twenty-First Century

FDA in the Twenty-First Century

Cohen, I. Glenn, Lynch, Holly Fernandez

0 / 0

Avez-vous aimé ce livre?

Quelle est la qualité du fichier téléchargé?

Veuillez télécharger le livre pour apprécier sa qualité

Quelle est la qualité des fichiers téléchargés?

Catégories:

Business & Economics - Industries

Année:

2015

Editeur::

Columbia University Press

Langue:

english

ISBN 10:

0231540078

ISBN 13:

9780231540070

Fichier:

PDF, 2.64 MB

IPFS:

,

english, 2015

Lire en ligne

La conversion en est effectuée

La conversion en a échoué

Cela peut vous intéresser

Florence R. Parker — FDA Administrative Enforcement Manual

Ronald Evens — Drug and Biological Development: From Molecule to Product and Beyond

DAVID CAVAIIA — OFF-IABEI PRESCRIBING-JUSTIFYING UNAPPROVED MEDICINE

Regulatory Affairs Professionals Society. — Fundamentals of Pharmaceutical and Biologics Regulations Volume I

Philippe Auby — Clinical Research in Paediatric Psychopharmacology: A Practical Overview of the Ethical, Scientific, and Regulatory Aspects

Divya Vohora; Gursharan Singh — Pharmaceutical Medicine and Translational Clinical Research

Javed Ali, Sanjula Baboota — Regulatory Affairs in the Pharmaceutical Industry

United States — Office of Technology Assessment. Pharmaceutical R And D: Costs, Risks And Rewards

Ira R. Berry — Introduction to the Pharmaceutical Regulatory Process

Cohen, I. Glenn; Lynch, Holly Fernandez — FDA in the twenty-first century : the challenges of regulating drugs and new technologies

Holly Fernandez Lynch (editor); I. Glenn Cohen (editor) — FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies

Leslie A. Pray, Sally Robinson — Challenges for the FDA: The Future of Drug Safety, Workshop Summary (Forum on Drug Discovery, Development, and Translation)

Institute of Medicine; Board on Population Health and Public Health Practice; Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process; Theresa Wizemann — Public Health Effectiveness of the FDA 510(k) Clearance Process : Balancing Patient Safety and Innovation: Workshop Report

Clinical Professor Ronald P. Evens Pharm D., FCCP (auth.), Clinical Professor Ronald P. Evens Pharm D., FCCP (eds.) — Drug and Biological Development: From Molecule to Product and Beyond

Smita Gopalaswamy (Author); Venky Gopalaswamy (Author) — Combination Products: Regulatory Challenges and Successful Product Development

Pintauro, Stephen J — The regulation of dietary supplements: a historical analysis

Lionel D. Edwards, Andrew J. Fletcher, Anthony W. Fox, Peter D. Stonier — Principles and Practice of Pharmaceutical Medicine, Second Edition

Fran Hawthorne — Inside the FDA: The Business and Politics Behind the Drugs We Take and the Food We Eat

John Griffin, John O'Grady — Regulation of Medical Products

Daniel Carpenter — Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA (Princeton Studies in American Politics: Historical, International, and Comparative Perspectives)

Thomas M. Jacobsen, Albert I. Wertheimer — Modern Pharmaceutical Industry: A Primer

Paul Ruschmann — Prescription and Non-prescription Drugs (Point Counterpoint)

Henry I. Miller — To America's Health: A Proposal to Reform the Food and Drug Administration

Norman F. Estrin — The Medical Device Industry

Pronobesh Chattopadhyay & Danswrang Goyary — Modern Medicine Biomedical Devices, Medical Gases, Radiopharmaceuticals, New Drug Discovery, Volume 2

Cavalla, David — Off-label prescribing : justifying unapproved medicine

Jeffrey S. Barrett — Fundamentals of Drug Development

Daniel Carpenter — Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA

Howard L. Dorfman — Pharmaceutical Compliance and Enforcement Answer Book 2016

Smita Gopalaswamy, Venky Gopalaswamy — Combination Products: Regulatory Challenges and Successful Product Development

R. Berry Ira, Robert P. Martin — The Pharmaceutical Regulatory Process

Douglas J. Pisano, David S. Mantus — FDA regulatory affairs : a guide for prescription drugs, medical devices, and biologics

Frantzeska Papadopoulou — Evergreening Patent Exclusivity in Pharmaceutical Products: Supplementary Protection Certificates, Orphan Drugs, Paediatric Extensions and ATMPs

Steven Strauss — Strauss's Federal Drug Laws and Examination Review

Douglas J. Pisano, David Mantus — FDA Regulatory Affairs: A Guide for Prescription Drugs, Medical Devices, and Biologics

Stephen J. Ceccoli — Pill Politics: Drugs and the FDA

Mots Clefs